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Abstract. The study of life and living organisms and the way in which these interact and organize to form social communities
have been central to my career. I have been fascinated by biology, neurology, and neuropathology, but also by history,
sociology, and art. Certain current historical, political, and social events, some occurring proximally but others affecting
people in apparently distant places, have had an impact on me. Epicurus, Seneca, and Camus shared their philosophical
positions which I learned from. Many scientists from various disciplines have been exciting sources of knowledge as well.
I have created a world of hypothesis and experiments but I have also got carried away by serendipity following unexpected
observations. It has not been an easy path; errors and wanderings are not uncommon, and opponents close to home much
more abundant than one might imagine. Ambition, imagination, resilience, and endurance have been useful in moving ahead
in response to setbacks. In the end, I have enjoyed my dedication to science and I am grateful to have glimpsed beauty in it.
These are brief memories of a Spanish neuropathologist born and raised in Barcelona, EU.
Keywords: Neuropathology
I have been invited to write a paper about my career
to commemorate the 20th year of publication of the
Journal of Alzheimer’s Disease. I am honored and
pleased by this proposal. This is a new experience.
I am moved by curiosity. Therefore, this is an exer-
cise which will attempt to summarize and to position
my public life mainly, but not exclusively, manifested
by medical practice and teaching, and research on
neurological diseases. I am 67 years old, and I have
grown up with the world’s current events. These have
permeated and imprinted my life, and I have inter-
acted with them. Therefore, these personal memories
are not restricted to research but they are put into the
context of several circumstances which had an impact
on me.
Other aspects are private, and the only comment is
to mention my love and gratitude to my family and
to my close friends.
∗Correspondence to: Isidro Ferrer, MD, PhD, Department
of Pathology and Experimental Therapeutics, University of
Barcelona, campus Bellvitge, Feixa Llarga sn, 08907 Hospitalet
de LLobregat, Spain. Tel.: +34 93 4035808; E-mail: 8082ifa@
gmail.com.
I was born in 1951, obtained my degree in medicine
in 1976, and PhD in 1978 at the Faculty of Medicine,
University of Barcelona. I learned neurology and
neuropathology in parallel, created the Unit of Neu-
ropathology at the Bellvitge University Hospital in
1980, obtained the title of Professor of Pathology
in 1986 and full Professor in 1996 at the University
of Barcelona, holding the chair of Pathology at the
campus of Bellvitge (Fig. 1).
But to understand the whole process and, more
importantly, to have an idea about the situation in
Spain at that time, some pieces of information are
needed. I was born into a liberal family belonging
to the Catalan bourgeoisie. Years in school were
marked by the dictates of the Franco regime accom-
panied by flashes at home of political discomfort and
expressions of need for change. Years in the uni-
versity encouraged total mental reconstruction and
substitution of the faked history we had learned,
and adherence to better elaborated ethical and moral
values. Deep concern for freedom, human rights,
and defense against dictatorship and manipulation of
information and of abuse of power were a natural
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Fig. 1. In February 1951, the Barcelona authorities announced a 40% rise in tram fares. Agitation against the rise began immediately. Around
97% of tram users joined the boycott on the first day, and by March 4 this figure had risen to 99%. Several days later the authorities caved and
the old fares were reinstated. I was born the 8 of April of that year in Rambla Cataluña unaware that a tram line circulated in both directions.
effect. No less important was the impact and active
positioning in the face of the new fresh feelings and
aspirations derived from the flower power revolution
of the 1960s. Those were subversive and passionate
days.
Francisco Franco died in November 1975 and the
new period was celebrated, first with some fear fol-
lowed by hope and enthusiasm. The desire was so
widely felt that it made possible engagement and
commitment of all democratic forces and the vast
majority of people to work together in a paradigm
of peaceful transformation of a dictatorship into a
democratic state. This background was subsequently
enriched by the conviction that a united European
Community and the continuous fight for the ful-
fillment of human rights all over the world and
particularly those of children, women, and minorities
was essential for humans to gain dignity.
1976–1990
At school I was inspired by my teachers in natural
sciences and art. I decided to study medicine. At the
time of obtaining my degree, neuropathology barely
existed in Spain; only a few pioneers coming from the
field of neurology were interested in this discipline.
Dr. Carmen Navarro was my mentor and master. I am
grateful for having had the opportunity to learn from
several people but her influence was decisive.
I started at the Bellvitge University Hospital,
formerly Princes of Spain Hospital. From the begin-
ning, our work encompassed clinical neuropathology,
teaching, and research. Clinical neuropathology
included postmortem neuropathology, muscle and
nerve pathology, brain tumors, and skin and other
biopsies for the diagnosis of metabolic and degen-
erative diseases in children. At that time, I was also
consultant neuropathologist at the Saint John of God
Children’s Hospital in Barcelona.
Regarding research, earliest studies were based on
the application of the Golgi method to the analysis
of human brain malformations and neurodegenera-
tive diseases. This was due to the fact that we had
no budget for research; yet osmium tetroxide and
silver nitrate for electron microscopy and current
silver impregnations for histology were readily avail-
able at the Department of Pathology. No funds for
research were available; research was carried out at
our expense.
The first paper published in an international jour-
nal was “Lissencephaly: a study with the Golgi
method” in 1976 [1] and the second “Multi-
cystic encephalopathy” in 1978 [2]. These were
followed by several publications using the rapid
Golgi method to learn about human brain mal-
formations of the cerebrum and cerebellum, other
developmental disorders, spine dysgenesis, and
central gangliogliomas. Another focus of interest
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was neurodegenerative diseases in children and in
adulthood such as ceroid-lipofuscinoses, lipidoses,
mucopolysacharidoses, Alzheimer’s disease (AD),
and Creutzfeldt-Jakob disease (CJD) [3–15]. The
effects of chronic alcoholism during development,
adolescence, and adulthood were also assessed in
human brains of infants with fetal alcohol syndrome
and in rat models. Devastating effects on dendritic
spines of cortical neurons and dendritic arbors of
Purkinje were also evidenced in adult chronic ethanol
abusers [16–20]. The Golgi method was powerful
when properly used to recognize the abnormal cel-
lular organization of the brain, and the structure of
neurons, their branches, and dendritic spines.
Now, it is practically forgotten, but the seven-
ties and eighties were a golden age for the Golgi
method applied to human neuropathology. Works of
M. Marı́n-Padilla, D.P. Purpura, V.S. Caviness, R.S.
Williams, M.S. Scheibel, R.S. Sheibel, S. Takashima,
H. Braak, E. Braak, and ours, among others, reported
for the first time alterations later re-discovered
using electron microscopy and immunohistochem-
istry. Rest assured that pictures and lessons drawn
from Santiago Ramon y Cajal were floating in my
mind.
I was also interested in the comparative structure
and organization of the cerebral cortex in different
species and in the formation of cerebral convolu-
tions. The rapid Golgi method proved useful by
revealing in detail the five-layered structure of the
cerebral cortex in insectivora (hedgehog, common
European mole), insectivorous bats (Myotis myotis),
and dolphins (Stenella coeruleoalba) due to the lack
of layer IV and the arrival of specific and non-specific
thalamic connections in the molecular layer with
the subsequent enlargement of neurons located in
layer II. This happened about 70 million years ago
when some primary insectivores remained on the
ground whereas others started to fly and still others
went into the oceans. Other aspects were assessed
in carnivore, feline, lagomorpha, and murine brains.
Insights to understand mechanisms contributing to
cortical remodeling in human brain malformations
were highlighted looking at the plastic neuronal mod-
ifications of ensuing mechanical forces and selective
cell death in convoluted brains [21–27].
Historical notes
The transition from Franco’s death until the
approval of the Constitution in 1978 was not easy.
Several radical forces stoked instability. On the one
hand, there was a subset of military forces and
extreme-right groups and on the other the terrorist
organizations ETA and GRAPO, both of them born in
Franco’s time but with increased capacity for bomb-
ing and assassination after the passing away of the
dictator. Prime Minister Adolfo Suarez was the main
builder of the new state and King Juan Carlos I played
a cardinal role in that period. The legalization of
the Communist Party and the amnesty to political
prisoners undermined misgivings. The first general
elections held in June 1977 were won by the Moder-
ate party (UCD) created by Adolfo Suarez. Socialists
were second followed by the Communists and the
Conservative parties. Nationalist parties PNV and
CiU took root in the Basque country and Catalonia,
respectively. The constitution of 1978 was based on
negotiation, consensus, and respect for the regional
autonomies; it was presented to a national referendum
and finally approved by 88% of affirmative votes.
A military coup occurred in 1981 but the putsch
was rapidly controlled. Yet UCD burned out as a con-
sequence of internal and external pressure, and the
Socialist party won the elections of 1982. GRAPO
declined in 1982 and finally dismantled in 1985.
ETA’s terrorism continued with assassinations. The
persistence of ETA was explained by the support of
a percentage of the Basque country fighting for an
independent Basque Nation. This has kept going until
recently.
On June 1985, the Treaty and the Agreement of
Adhesion to the European Community were signed;
Spain was eventually admitted as an active full mem-
ber the first of January of the next year. Nearly at
the same time, Spain, still under the Government
of the Socialist party, entered NATO in spite of
strong social opposition. These were important com-
mitments which stimulated political and social ties,
inspired a sense of European membership with shared
responsibility and duties, and stirred entrepreneur-
ship.
Belonging to the European Community had posi-
tive effects on science, facilitating collaborations and
funding for research. The euro was not introduced
until several years later and accepted as the common
currency for 19 of 28 countries in 2002.
1990–2000
The work titled “Cell death in the cerebral cortex of
the rat and removal of dead cells by transitory phago-
cytes” was published in 1990 [28] and described the
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appearance of dying cells with the morphological
characteristics of apoptosis in the somatosensory and
medial cortical regions, as well as in the cortical sub-
plate of the rat. Cell death occurs during the first ten
days after birth, and reaches a peak on day seven to
decrease thereafter.
Dying cells predominate in the upper cortical lay-
ers (future layers II-III) and sub-plate in relation to the
arrival and settlement of the cortical afferents in the
cortex thus suggesting that transient cells are involved
in the modulation of the final structure of the cere-
bral cortex. The neurons of the sub-plate serve as
scaffolding to help the arrival of the afferents in the
brain cortex.
The study was conducted at a time in which
several researchers were engaged in trying to under-
stand neurogenesis and gliogenesis in the brain, the
development of connections including dendrites and
axons, and the phenomenon of transient events dur-
ing corticogenesis in which populations and cellular
processes are produced in excess in order to be later
destroyed, thus allowing fine organization of the cere-
bral cortex.
That study continued with research focused on the
dating of the birth of neural precursors in the periven-
tricular germinal layer, the migration process, and the
final localization of particular neural populations in
the cerebral cortex [29–32].
Specific markers of DNA replication confirmed a
gradient of cell migration in the cerebral cortex by
which molecular layer neurons and the neurons of the
sub-plate were the first to migrate, while neurons of
the cortical plate migrate along a gradient in which the
neurons of the inner layers migrate first followed by
the neurons of the middle layers and then the neurons
that make up the upper layers.
Amoeboid microglia cells were first described by
Pı́o del Rio Hortega. These cells migrate from the
wall of the ventricles and sub-cortical white mat-
ter to the cortical plate and pial surface. Amoeboid
microglia, among other functions, are responsible for
the removal of dying cells and are involved in cortical
remodeling in the developing brain.
The paper was published at the same time as
another describing the pattern of cell death in the
development of the hippocampus and the subiculum,
and was followed by a review of these events in the
brain of rodents [33].
Research during the following years focused on
different facets. Efforts were made to characterize cell
death during development as an active process, linked
to caspase-dependent apoptosis. On the other hand,
the concept of natural death served to introduce the
idea of pathological cell death during development
which led to the generation of rat models in which
there was selective cell death using a single dose of
ionizing radiation on defined days of gestation.
This project was funded by a European program to
study the effect of ionizing radiation on the nervous
system as a result of the Chernobyl nuclear disas-
ter in 1986 in Ukraine, which produced radioactive
contamination in many European countries.
Through this approach, models of microen-
cephaly, several cortical malformations such as
sub-cortical heterotopy, four-layered lissencephaly,
non-laminated microgyria, and several types of cor-
tical dysplasia affecting the upper cortical layers
were generated to learn about the dating and mech-
anisms involved in cerebral cortical malformations.
The rapid Golgi method, accompanied by immuno-
histochemistry, was the main tool to recognize fine
alterations of neurons, altered cortical organization,
and abnormal spines [34–37].
The interest in natural and induced cell death dur-
ing development extended to the study of the role
of apoptosis in several pathological conditions of
hypoxia-ischemia in experimental models of focal
and global ischemia in developing and adult models,
and in animal models of neurodegeneration induced
by various agents.
Apoptosis was identified as a common cause of cell
death following hypoxia-ischemia in newborn rats.
Apoptosis and intermediate forms between apop-
tosis and necrosis occurred after global ischemia
in rats and gerbils. By contrast, necrosis was the
paradigm of cell death in the core of the infarct
following focal ischemia, while apoptosis predomi-
nated in the periphery in the area known as penumbra
where neurons and glial cells struggle for survival.
This turned to be a very important feature as reduc-
tion of the penumbra area by administration of
selected drugs reduced the final area of infarction
and potentially reduced residual neurological dam-
age following stroke. Rapid intervention was crucial
at this point [38–46].
Several experiments were carried out using exci-
totoxic agents to glean information about the type of
cell death in models of neurodegeneration in which
glutamatergic excitotoxic damage was assumed to
play a primary role such as in Huntington’s disease
(HD) and epilepsy. Our observations showed that
the type of cell death was not apoptosis or necro-
sis but rather a mixed form that was accepted as
such in subsequent experiments. Long-term studies
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showed plastic aspects of adapted connectivity fol-
lowing excitotoxic and ischemic damage. Some of
these were useful to better understand remodeling of
the hippocampus in models of epilepsy [47–51].
Similar methods were employed in human brain
samples with neurodegenerative diseases. Apopto-
sis was at that time considered the main cause of
cell death in AD, HD, and Parkinson’s disease (PD),
among others. However, different mechanisms con-
verge in the degeneration and death of nerve cells.
With the exception of CJD, scrapie, and inflamma-
tory diseases of the brain and the spinal cord which
showed the presence of apoptosis, cell death classed
as apoptosis described in AD and other neurodegen-
erative diseases was mostly an artifact related to the
DNA fragmentation linked to agonic state and post-
mortem delay between death and tissue processing
[47, 52–56].
The last decade of the twentieth century was cardi-
nal for clinical research in Spain, since the first calls
for projects of the Health Research Fund (FIS) of
the Institute of Health Carlos III, under the Ministry
of Health, led to the funding of projects oriented to
clinical and experimental applied research in human
disease. FIS calls produced a tremendous change
in medical research and represented a fruitful com-
plement to those already funded by the Ministry of
Education and Science.
Historical notes
Reviewing the work of natural death during devel-
opment, I look at what happened in the world in
the year 1990. The world’s population was about
5,264,000,000 people—in Africa: 625,000,000; in
Asia: 3,168,000,000; in Europe: 722,000,000; in
Latin America: 442,000,000; in North America:
284,000,000; and in Oceania: 27,000,000. In 1990,
there were important political events including the
reunification of Germany and the fall of the Berlin
wall; invasion of Panama by the USA; declaration
of independence of the Baltic States from the Soviet
Union in the context of Perestroika and Glasnost; col-
lapse of the Communist regime and emergence of the
new republics in the former Yugoslavia; beginning of
the crisis in the Persian Gulf that would lead to the
Gulf war in 1991 after the invasion of Kuwait by Iraq;
and a formal declaration of the end of the Cold War
by the leaders of Canada, the United States, and 32
European States meeting in Paris.
Regarding science, just a few highlights during
1990 which represent the amazing revolution during
the last century and the beginning of twenty-first: for-
mal start of the Genome Project; launch of Hubble
space telescope; beginning of the history of the Inter-
net in the fall of 1990, when Tim Berners-Lee created
the first server and the founding of the World Wide
Web; and the first case of successful gene therapy in
a human being.
After the end of the Cold War, Yugoslavia fell apart
and original nations sought to organize as individual
states. The first war in 1991 ended with the indepen-
dence of Slovenia, although its borders were not safe
for longtime. Croatian war of independence against
Serbia lasted about five years and was escalated by
massacres not seen in Europe since the Second World
War. The Bosnian war involving Serbia, Bosnia, and
Herzegovina, occurring almost in parallel, was both
an ethnic and religious war in which fighters were
Serbians, Bosnian Croats, and Bosniaks, but also
Christians against Muslims. The Kosovo war during
1998 and 1999, and the insurgencies in the Pre-
sevo valley and the Macedonian Republic from 1999
to 2001, ended with shame and regional instability.
Divided Bosnia and failed Kosovo are a matter of
concern still today.
The first Gulf War started in 1991; the Iraq war in
2003 leading to Iraq’s collapse, imbalance of forces
in the region and civil war aftermath are still not
solved. At the time, genocide occurred in Rwanda,
chaos in Uganda and in the Democratic Republic of
Congo. Sierra Leone’s civil war started in 1991 and
was not finished until the military intervention of the
UK in 2002 to defeat the Revolutionary United Front
and its ally Charles Taylor’s National Patriotic Front
of Liberia. As a counterpart, Nelson Mandela was
elected president of South Africa in 1994.
Some years later, I initiated a cooperative work
focused on health infrastructures in Sierra Leone.
Several administrative difficulties together with the
arrival of the Ebola killing key local collaborators
ruined previous efforts and aborted the whole project.
From a local perspective, a turning point in
Catalonia in 1990 was the Catalan Government
debate document purporting to be the ideological
program of the Democratic Convergence of Catalo-
nia party during the next decade that served as a
base for the regional elections of 1992. The doc-
ument equated Catalonia with the Paı̈sos Catalans
understanding them as the zone of influence of the
communities of Catalonia, Valencia, and part of the
southeast France. The document also stated that Cat-
alonia is a nation discriminated against which cannot
freely develop its cultural and economic potential.
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Fig. 2. Barcelona and Cobi, the mascot for the Barcelona 1992, by Javier Mariscal, an interdisciplinary artist born in Valencia, working and
living in Barcelona since 1970.
The political objectives for the future were to control
the composition of the courts, monitor the devel-
opment of the regulations on the catalanization of
education, place nationalists in key places in the
media, qualify the positions in financial institutions,
influence the administration of justice and public
order with national criteria, and review the mecha-
nisms of access and promotion of civil services.
Put into practice, these principles mark the history
of Catalonia in the last twenty-five years. Alternation
of the Socialists and Conservatives in the Spanish
government did not have any influence on the pro-
gressive implementation of the nationalist program.
The Olympic Games celebrated in Barcelona in
1992 put the city on the international map and
revealed one of the most pleasant cities in the world
(Fig. 2).
2000–2010
During the previous years, a brain bank was devel-
oped, from clinical autopsies of indoor patients dying
from various diseases, as a facility of the Unit of Neu-
ropathology at the Bellvitge University Hospital. This
permitted the collection of brain samples obtained
under optimal conditions of short postmortem delay
together with rapid freezing of a wide selection
of representative brain regions. Importantly, cases
were from middle-aged controls, individuals with
early stages of neurodegenerative diseases, and aged
individuals, as well as from patients who had suf-
fered from neurodegenerative disease and stroke. The
bank grew in parallel with that of the University of
Barcelona located at the Clinic Hospital which was
focused on donors affected by neurodegenerative dis-
eases. Together, the banks were complementary as
they included control cases, and early, advanced, and
terminal stages of major neurodegenerative diseases,
and rare neurological disorders.
In addition, and in the context of the prion cri-
sis at the beginning of this century, I acted as a
scientific advisor of the Spanish Survilliance Com-
mission with members of the Ministries of Health
and Economy, and at the Department of Health of the
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Autonomous Government for two years. The man-
agement of the crisis was complicated but effective.
The creation of a network of local and reference cen-
ters permitted the control of the spongiform bovine
encephalopathy and the follow-up of the vast major-
ity of patients with rapid dementias. After careful
screening over the years, only a few vCJD cases were
recorded in Spain. A reference center for studies of
prion diseases was also created by the Department
of Health in which tasks were shared by the two
complementary brain banks. The biosecurity facility
for molecular studies of human prion diseases was
fully at work at that time at the Bellvitge University
Hospital.
The Research Network Centre of Neurological
Diseases (CIEN) managed by the CIEN Foundation
was created by the Ministry of Health independent
of the Institute Carlos III. The rationale of the net-
work was to obtain advantage of the main excellent
groups working on different topics of basic and clini-
cal neuroscience located in different centers. Groups
participating in the network were selected after pass-
ing thresholds defined in a call with external revision
of the merits; they received a basal budget and addi-
tionally funds depending on internal collaborative
projects. The idea was not the construction of new
buildings but rather to finance research networks by
incorporating new members in selected groups and
funding big collaborative projects. Small adminis-
trative team and minimal equipment was needed to
manage the network. I was in charge of the direc-
tion of CIEN. The huge experiment was a failure
because of the difficulty to assemble and coordinate
very different disciplines; too ambitious and exten-
sive. But the experience was very useful and served
to create another model centered on particular top-
ics. The new model was based on the CIBERs and
RETICs (Biomedical Research Networking Centers
and Networks for Cooperative Research in Health,
respectively).
Dedication to two projects in Catalonia kept me
busy for a period of time. One of them was the
design of the Catalan Institute of Neuroscience Net-
work, the other the organization of the Catalan Brain
Bank Network both dependent on the Catalan Depart-
ment of Health. The Institute of Neuropathology was
created in 2003 as a branch of the Catalan Insti-
tute of Neuroscience. It included laboratories located
in the Bellvitge University Hospital, University of
Barcelona, and the neighboring Hospital Duran i
Reynals. However, the rest of the project was unsuc-
cessful; the Catalan Institute of Neuroscience was
aborted due to internal quarrels within the Depart-
ment of Health.
A coordinated program of Catalonian brain banks
including those of the Institute of Neuropathology,
the Clinic Hospital, the brain bank of psychiatric
diseases at Saint Boi Hospital, and the Pediatric
Bank at the Saint John of God Hospital was ini-
tially financed by Pharma Industry. Unfortunately,
the creation of the Catalan Brain Bank network was
not considered a priority by local health authorities;
only the two larger brain banks continued to work
separately based on their own resources.
In the meantime, the University Hospital of
Bellvitge, the Hospital Duran I Reynals, and
the University of Basrcelona, Bellvitge campus,
together with other members, formed the Institute of
Biomedical Research Bellvitge (IDIBELL), a robust
consortium and foundation, aimed at developing col-
laborative biomedical research.
BrainNet Europe was a “Network of Excellence”
funded by the European Commission in the 6th
Framework Program “Life Science” (LSHM-CT-
2004-503039). It consisted of 19 established brain
banks across Europe and was coordinated by the
Centre for Neuropathology and Prion Research
Ludwig-Maximilians-University Munich, Germany
led by Professor Hans Kretzschmar. The comprehen-
sive approach to brain banking from management,
ethical concerns in the search for common proto-
cols, and collaborative studies geared to a better
classification and understanding of neurological dis-
eases, and the advances in molecular procedures
adapted to the use of human postmortem material
had tremendous consequences; every member of the
consortium did their best to produce a plethora of use-
ful practical information for neuropathological and
molecular studies of neurodegenerative and mental
diseases.
Another important European Consortium, Neuro-
prion (funded under FP6-FOOD, Id: 506579), was
composed of 52 partners representing 120 research
teams distributed in 20 countries. Neuroprion encom-
passed more than 90% of the European teams
working on prions (more than 50% at the worldwide
level) and lasted from 2003 to 2009.
Indabip was a European collaborative project
geared to the study of PD (funded under FP6-
Lifescihealth, Id: 37050) which was formed by three
academic teams and two companies. Indabip started
in 2006 and had duration of three years.
The Institute of Neuropathology participated in
the three major projects, and received in addition
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funds for research from Spanish agencies (FIS) and
Foundations. The first decade of the twenty-first
century represented a fruitful period for the Insti-
tute. From the late nineties, about twenty years on
from the beginning, an increasing number of techni-
cians, undergraduate students, pre- and post-doctoral
researchers, and researchers from different disci-
plines worked in our laboratories.
Main lines of research were re-directed and
focused on neurodegenerative diseases with abnor-
mal protein aggregates, and particularly molecular
aspects involved in the pathogenesis of these diseases.
Mechanisms of cell death in different paradigms
were assessed contributing to better knowledge of
mechanisms involved in apoptosis. The observa-
tion of altered expression of neurotrophic factors,
particularly BDNF and its receptors, in AD and
cerebral cortex in HD was pioneering. In AD,
decreased BDNF expression, and altered specific
receptor expression and localization, indicate defec-
tive BDNF signaling. Therefore, treatment with
BDNF appeared not to be a suitable therapeutic
approach in AD. In contrast, decreased BDNF expres-
sion in frontal cortex in HD suggested impaired
neurotrophic availability in the striatum, and pin-
pointed BDNF administration as a putative element
to increase neuronal survival in the striatum in HD
[57–59]. Altered pro-NGF expression in AD was
accompanied by reduced cell survival in cultured
cells and the process was mediated by p75NTR. This
observation suggested abnormal pro-NGF signaling
in AD as a contributory factor to increased neuronal
vulnerability [60].
Another focus of study was the characterization
of mechanisms linked to phospho-tau production
and deposition in AD and diverse tauopathies,
and to the characteristics of abnormal -synuclein
in Lewy body diseases (LBD) and multiple sys-
tem atrophy (MSA). Previous observations had
shown the implication of several kinases in tau
phosphorylation in vitro. We demonstrated the
presence and co-localization of glycogen synthase
kinase-3, active p38 (P-38P), active stress-activated
protein kinase/c-Jun kinase (P-SAPK-JNK), and
active mitogen-activated protein kinase (P-MAPK-
ERK1/ERK2) in neurons (and glial cells) containing
hyperphosphorylated tau in AD and tauopathies,
progressive supranuclear palsy, corticobasal degener-
ation, familial frontotemporal lobar degeneration due
to tau mutations (FTLD-MAPT/tau), argyrophilic
grain disease (AGD), and Pick’s disease (PiD). More-
over, immunoprecipitated kinases obtained from the
brain of AD and PiD cases had the capacity to
phosphorylate specific substrates including recom-
binant tau [61–69]. On the other hand, abnormal
-synuclein in LBD and MSA had abnormal solubil-
ity and aggregation. Importantly, abnormal synuclein
had aberrant interaction with certain Rab proteins
such as Rab3, Rab 5, and Rab 8, thus impairing
the transportation of synaptic vesicles from the stor-
age compartment to the synaptic membrane in PD,
dementia with Lewy bodies (DLB), related murine
models bearing -synuclein mutations, and MSA.
Abnormal -synuclein in DLB also contributed to
signaling decay of cortical metabotropic glutamate
receptor by irregularly interacting with phospholi-
pase C [70–72].
A pioneering observation was that abnormal
phosphorylated tau was not only observed in
synaptosomal-enriched fractions in AD but also, to
lesser degree, in cortical synapses in PD (without AD
co-morbidity), and that abnormally phosphorylated
-synuclein (Ser129) was found in synaptosomal-
enriched fractions in cerebral cortex not only in PD
but also in AD. Moreover, abnormally phosphory-
lated -synuclein was identified in PiD [73, 74].
Contribution to the knowledge of altered mod-
ulation of neurotransmission in neurodegenerative
diseases was exemplified by defects of adenosine
A1 receptor (and A2A) and metabotropic glutamate
receptor signaling in AD, PiD, and LBDs, among
other neurodegenerative disease [75–79].
Altered expression of certain mitochondrial pro-
teins was identified in AD and LBDs. Moreover,
activity of complex V (ATP synthase) was reduced in
entorhinal cortex at very early stages of age-related
neurofibrillary tangle pathology. Altered activity of
various mitochondrial complexes was also demon-
strated in the cerebral cortex at advanced stages of
PD and DLB [80–83].
Molecular alterations linked to unbalanced oxida-
tive stress and oxidative stress responses were
identified in AD, PiD, progressive supranuclear palsy,
HD, and -synucleinopathies. Redox proteomics
further demonstrated vulnerable targets such as
-synuclein, enolase, aldolase, and glyceraldehydes-
3-phosphate dehydrogenase in the cerebral cortex at
early pre-motor stages of PD [84–88].
Several studies were focused on PrP and prion
diseases, particularly on CJD. Cell death via apop-
tosis, decreased expression of synaptic proteins,
altered expression of ionotropic glutamatergic and
GABergic receptors, metabotropic glutamate recep-
tors, adenosine A1 receptors, defective expression
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of factors involved in protein synthesis, abnormal
clusterin solubility and aggregation, and disturbed
expression of water channel aquaporin 4 were iden-
tified in CJD. Increased glycoxidation, lipoxidation,
nitration, and responses to oxidative stress were also
demonstrated in CJD. Reduced expression of synap-
tic proteins, and impaired expression of group I
metabotropic glutamate and adenosine 1 receptor sig-
naling, were also demonstrated in the cerebral cortex
in a murine model of scrapie [89–94].
Interestingly, cellular PrP was expressed in
senile plaques (thus showing a relationship between
amyloid- and cellular PrP) whereas doppel (a PrP-
like protein) was located in dystrophic neurites of
senile plaques [95, 96].
Closely linked to neurodegenerative diseases of
the central nervous system are certain diseases of
the striate muscle and heart, as inclusion body
myositis and myofibrillar myopathies. The latter
are characterized by the accumulation of abnormal
protein aggregates in muscle (and heart), such as
desmin and myotilin. Several papers described and
characterized desminopathies and myotilinopathies;
several proteins such as synemin, tau, and phos-
phorylated TDP-43 were also components of such
abnormal deposits. Altered expression of clus-
terin, components of the aggresome, components of
the ubiquitin-proteasome system, activation of the
immunoprotesome, and local presentation of MHC
class I were also discovered during this time. Follow-
ing the same approach as in other neurodegenerative
diseases, assessment of oxidative stress and responses
in myofibrillar myopathies revealed increased oxida-
tive damage and increased expression of oxidative
stress responses. Redox proteomics further identified
desmin as one of the protein targets of oxidative stress
damage in this group of muscular diseases [97–104].
The work carried out in collaboration with a large
number of scientists of BrainNet was a useful experi-
ence. Some studies were designed to find agreement
about methods, gradation, and reproducibility of
major pathologic markers of disease such as neuritic
plaques, neurofibrillary tangles, amyloid-, phos-
phorylated tau, -synuclein, and TDP-43, as well as
in combined pathologies in the elderly. Other stud-
ies were centered on the identification of markers
of tissue preservation considering antemortem and
postmortem factors; optimization and limitations of
DNA, DNA methylation, histones, RNA and pro-
tein studies in postmortem human samples from
brain banks. Another group was focused on partic-
ular aspects such as sampling in banks of psychiatric
diseases, general management of brain banks, and
ethical concerns [105–115].
Studies refined aspects of cell death in the penum-
bra after ischemia and prenatal cell death in motor
neuron disease [116–118]. Other studies include the
second report of neuropathological alterations and
immunoprotesome activation in AD encephalitis fol-
lowing amyloid- immunization which was followed
by several collaborative studies on the effects of
amyloid- immunization; the first description of a
novel mutation (K317M) in MAPT causing FTLD
and amyotrophic lateral sclerosis (ALS) with com-
plex neuropathology associated with the presence of
globular glial inclusions; one of the first descrip-
tions of globular glial tauopathy; new aspects of
AGD and PD; characterization of a family with early
onset familial LBD with dementia and extensive
tauopathy; NARP-MILS syndrome caused by a novel
mitochondrial DNA mutation; reduced ubiquitin
C-terminal hydrolase 1 (UCHL-1) expression in
DLB; and several reviews on brain vascular diseases
and cognitive impairment of vascular origin, among
others [119–128].
Two additional points of interest analyzed in
collaborative studies were X-linked adrenoleukodys-
trophy (X-ADL) and veterinary neuropathology.
X-ALD is a severe neurodegenerative disease
caused by loss of function of the peroxisomal trans-
porter ABCD1 (ALD), which results in accumulation
of very long chain fatty acids (VLCFAs) in organs and
serum, central demyelination, peripheral axonopa-
thy, and Addison’s disease. Knockout of the ALD
gene in the mouse results in an adrenomyeloneuropa-
thy (a late-onset form of X-ALD). Overexpression
of ALD-related gene (ALDR/ABCD2) in ALD KO
mice prevented accumulation of VLCFAs and neu-
rodegeneration. In contrast, double mutants for ALD
and ALDR exhibited an earlier onset and more
severe phenotype than ALD KO mice. This obser-
vation represented an advantageous starting point
to assess pathogenic factors of the disease and to
test drugs directed to specific targets. Subsequent
studies showed that inactivation of ALDR in the
mouse led to late-onset ataxia, involving mitochon-
dria, endoplasmic reticulum, and Golgi complex
damage. Moreover, oxidative stress and inflammation
were crucial pathogenic factors. A mini-symposium
on X-ALD was coordinated and published in Brain
Pathology to update knowledge of this neurodegen-
erative metabolic disease [129–131].
Veterinary neuropathology is often not properly
considered; in fact, specialization in this activity is
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rare. I have had the opportunity to study a large num-
ber of cases thanks to Dr. Martı́ Pumarola working
at the Veterinary Faculty of the Autonomous Univer-
sity of Barcelona. We have spent many hours peering
through the microscope in my home and discussing
difficult cases. It was diagnosis but also clinical
research. We studied the aging canine brain, juvenile
neuroaxonal dystrophy in Rottweiler, degenerative
myeloencephalopathy in Arabian horses, spongiform
encephalopathy in a kitten, neuronal intranuclear
inclusion disease in a horse, and motor neuron dis-
ease in calves. The study of late neurodegenerative
disease in the albino gorilla Snowflake, resident
in the Barcelona Zoo, identified neurodegenera-
tion with brain iron accumulation type I. Some
papers were published in that period but fruit-
ful neuropathological debates are still alive today
[129–131].
Unfortunately, we failed in the creation of an ani-
mal brain bank linked to the Barcelona Zoo.
Historical notes
Several important historical and social events
occurred during the first decade of the twenty-first
century. Personal computers broke the 1 GHz bar-
rier in 2000; Wikipedia and iPod were launched in
2001; the first cyborg was created in 2002; the Human
Genome project was completed in 2003; Facebook
was launched in 2004, YouTube in 2005, and Twit-
ter in 2006; graphene was isolated in 2004; and USB
flash drives replaced floppy disks in 2005. George
Bush was elected president of the USA in 2001; the
Iraq war led by USA in partnership with the United
Kingdom and Spain started in 2003; Saddam Hussein
was captured and his execution by hanging in 2006
was widely broadcast.
That decade also globalized a new form of war. Ter-
rorist incidents, many with casualties, numbered 170
worldwide only in 2000, with twenty-two in Spain
carried out by ETA. A coordinated aerial terrorist
attack struck the USA in 2001 with more than 3,000
dead; another, Indonesia in 2002; a train attack killed
hundreds in Madrid, Spain in 2004; suicide bombers
killed and injured several hundred in London, UK
in 2005; multiple suicide bombings killed 700 peo-
ple in the north of Iraq in 2007. In all cases, terror
was expanded through the media with a multiplying
effect. New terrorists were fascinated and recruited
using the global media. Some years later, the journal-
ist James Wright was kneeling backwards to a ninja in
disguise in a remote desert; beheading was recorded
on video and exhibited worldwide as a presentation
of ISIS (Islamic State in Iraq and Syria).
One of the first responses against terrorism led by
al-Qaeda was the invasion of Afghanistan by the USA
in 2001 followed by the inclusion of NATO in 2003
in an attempt to reduce the Taliban’s power and trap
Osama bin Laden, which was not achieved until 2011,
killing him in Pakistan. Mujahadeen power, a pre-
cursor to the Taliban and formerly supported by the
USA in the fight of Afghanistan against the USSR
years before, has had devastating effects on the local
population and it is still alive today without control.
Vladimir Putin was President of Russia from 2000
to 2008, Prime Minister from 2008 to 2012, and again
President from 2012 until present. Angela Merkel has
been Chancellor of Germany since 2005, and her gen-
eral policy regarding the European Union is similar
that of Helmut Kohl, a key person in the construc-
tion of a peaceful and united Europe; Barack Obama
was sworn in as 44th President of the USA in 2009,
and Hu-Jintao the President of the People’s Repub-
lic of China from 2003 to 2013. The selection of
these names and countries is not random; they rather
reflect the major blocks that now lead and will model
the near future of our world. These players are not
unique and other Asian, European, and Latin America
emerging countries will also have a place as main
actors.
The terrorist attack in Madrid had political conse-
quences as it occurred three days before the general
elections; the Conservative party went down because,
in part, of the obtuse management of the catastrophe.
The Socialist party won the elections in 2004 and in
2008, remaining in power until 2011.
2010–2016
The European financial crisis started in 2008 and
was especially dramatic in certain European coun-
tries such as Portugal, Spain, and Greece. The crisis in
Spain was due, in part, to the housing bubble, together
with the lack of foresight and lack of attenuation
measures at the beginning of the crash. The cri-
sis had devastating effects on young people, macro-
and micro-economic indicators, and unemployment
rates. This was accompanied by alarming general-
ized corruption at all levels principally around local,
autonomous regional, and state governments, private
companies, and banks.
In 2008, the Spanish government promised a
new Silver Age of science that would comprise
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the creation of a new Ministry of Science together
with major, long-awaited investments in research and
development. Unfortunately, those expectations did
not translate into reality. The tabled 2010 national
budget proposed that funding for the Ministry of Sci-
ence should be cut by more than 15%, thus returning
to 2006 levels. In fact, the situation was more serious
given that the new Ministry also comprised the Health
Institutes, which were previously the oversight of the
Ministry of Health. Research institutions depending
on the ministry suffered up to a 30% reduction in
government contributions from 2008.
Despite this scenario, two important factors
contributed to the survival of the Institute of Neu-
ropathology. One of them was its membership in
CIBERNED (Network Research Center for Research
of Neurodegenerative Diseases) of the National Insti-
tute of Health Carlos III. CIBERNED had its origin
on the former CIEN (Research Network Centre of
Neurological Diseases) managed by the CIEN Foun-
dation. CIBERNED includes major groups focused
on clinical and translational research on neurodegen-
erative diseases, and finances internal collaborative
projects.
The other was the partnership in the European
Project DEVELAGE (FP7-HEALTH, 278486) led by
Dr. Gabor G. Kovacs of the Medical University of
Vienna, lasting from 2012 to 2014. The aim of the
project was to characterize shared molecular path-
ways between early developmental processes in the
brain, brain aging, and age-related neurodegenera-
tion. Institutional funding of projects by the Institute
of Health Carlos III and funding from private Foun-
dations were crucial in that period as well.
As a result, we were fortunate as the impact of
the crisis was attenuated excepting the notable fall
in salaries. However, the Unit of Neuromuscular dis-
eases decided to act independently and eventually no
clinical and research interaction was visible between
muscular diseases and central nervous system disor-
ders.
Collaborative studies in the context of BrainNet
continued during that period yielding several publi-
cations focused on vascular diseases, prion diseases,
and combined pathologies [137–143]. Characteriza-
tion of altered molecular pathways in the cerebral
cortex in AD, LBDs, HD, ALS, and prion diseases
also progressed following the use of combined -
omics.
Transcriptomics, proteomics metabolomics, and
lipidomics, followed by bioinformatic processing of
the data, were used in combination in selected brain
regions and determinate stages of disease, mainly in
AD and LBDs. This approach proved to be very fruit-
ful as it permitted researchers to assemble alterations
of multiple metabolic pathways in the pathogen-
esis of neurodegenerative diseases from a single
experimental design using the same methods and
same hands. Mitochondrial alterations and dysfunc-
tion of certain enzymatic complexes of the respiratory
chain and energy metabolism, alterations of protein
synthesis from the nucleolus to the ribosome, endo-
plasmic reticulum stress and chaperone activation,
deregulation of the UPS (including activation of the
immunoproteasome), altered autophagy, modifica-
tions in purine metabolism, and lipid composition
of membranes, especially of lipid rafts, were recog-
nized in all the diseases examined. However, altered
mRNA and protein expression differed from one dis-
ease to another, from one region to another, and from
one stage of the disease to another. These observa-
tions add complexity to the pathology of diseases
as never envisaged by the study of morphologi-
cal and immunohistochemical neuropathology alone.
The relation of these abnormalities with specific key
proteins was also examined mainly in LBDs includ-
ing the identification of abnormal -synuclein in the
nuclei, mitochondria, and synapses in frontal cor-
tex even at relatively early stages of the disease
[144–151].
These observations also have practical implica-
tions in many ways. For example, inflammatory
deregulation appears at early stages of the diseases
and is disease-, region-, and stage-dependent.
Therefore, modulation of inflammation in these
diseases cannot be solved at random but must be
target-directed. Alterations in lipid metabolism and
composition of lipid rafts are also disease-specific
[152–156]. Application of metabolomics proved
useful to increase understanding about selected
pathways [157].
A particular focus of study was tauopathies. We
showed mitochondrial dysfunction and endoplasmic
reticulum stress in AGD; new cases of GSS bear-
ing the PRNP P102L-129V mutation with extensive
tauopathy mimicking AD but without amyloid-
deposits; and characterization of thorn-like astro-
cytes followed by analysis of phospho-specific sites,
conformational modifications, and truncated tau
in astrocytes and neurons in various tauopathies
[158–161]. Another study showed definitive evidence
of 4R tau alterations HD [162]. Reviews focused on
early molecular alterations in AD and PD were pub-
lished [163, 164].
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Two international harmonized studies delineate the
spectrum of globular glial tauopathies (GGT) and
the concept of ARTAG (age-related tau astrogliopa-
thy) [165, 166]. GGT embraces distinct tauopathies
with globular inclusions in oligodendrocytes and
astrocytes with variable neuropathology and clinical
manifestations. ARTAG refers to the presence and
particular distribution of thorn-like astrocytes in sub-
pial, periventricular, and perivascular regions, as well
as clusters in the basal forebrain, and temporal and
frontal white matter; all of this is together with astro-
cytes with long processes and small varicosities in
the cerebral cortex.
Megalencephalic leukoncephalopathy with sub-
cortical cysts is a rare primary astrogliopathy linked
to mutations in MLC1. The mechanism of degen-
eration is due to the disruption between MLC1,
GLIALCAM, and CIC-2 which lead to glial chloride
channel dysfunction [167, 168].
ALS was the subject of several studies and it is an
active line of research, together with FTLD-TDP, in
our laboratories today. The first studies were centered
to learning about oxidative stress and reticulum stress
in the pathogenesis of ALS and related SOD1 trans-
genic mouse models. This was followed by attention
to TDP-43 changes induced by oxidative stress,
early and gender-specific differences in mitochon-
drial function, and oxidative stress in murine ALS,
as well as interplay between TDP-43 and docosahex-
aenoic acid-related processes in ALS transgenic mice
[169, 170].
Investigation in prion diseases was extended to
genetics, functions of cellular prion protein, and
alterations linked to pathogenic PrP [171–175].
Regarding functions of cellular prion protein, cel-
lular PrP ablation and cellular PrP overexpression
resulted in several modifications in gene expres-
sion, thus indicating the interaction of PrP with
other molecules. Among these, epidermal growth
factor receptor expression is regulated by PrP
expression levels; cellular PrP confers neuroprotec-
tion in front of excitotoxic-induced seizures; and
cellular PrP expression participates in the regula-
tion of tau protein levels and tau phosphorylation
in AD.
Following the same methods as those in other
neurodegenerative diseases, we demonstrated altered
mitochondria, protein synthesis machinery, purine
metabolism, and detailed inflammatory responses in
sporadic CJD. In the same line, new molecular defects
were reported in target brain regions in fatal familial
insomnia [176, 177].
The field of cerebrospinal fluid biomarkers was
also expanded in prion diseases, and in other neu-
rodegenerative and vascular dementias [178].
Epigenetic modulation was assessed in certain
diseases. We analyzed small pieces of interest which
were directed toward understanding particular alter-
ations of mRNA expression identified in previous
years. The expression of a few genes in AD was
modulated by DNA methylation whereas a vast
majority was not. Selected examples were the associ-
ation between hypermethylation of the phosphatase
DUSP22 promoter, PKA-dependent tau phospho-
rylation, and CREB activation in AD; and the
relationship between expression of certain cytokines,
but not others, and DNA methylation of the corre-
sponding promoters. On the other hand, human DNA
methylomes of neurodegenerative diseases showed
common epigenomic markers. Abnormal mitochon-
drial DNA methylation was also observed in the
substantia nigra in PD and in the cerebral cortex in
AD [179–183].
We identified early downregulation of miR-
34b/c in PD using micro-arrays; miR34b/c silencing
resulted in downregulation of mitochondrial function
in cell culture. Curiously, miR34b likely regulates the
striatal expression levels of A2AR at early stages of
PD. However, we still do not know how to assemble
all the factors which converge in altered mitochon-
drial function in LBDs [184, 185]. Long non-coding
antisense RNA controls Uchl1 translation through an
embedded SINEB2 repeat [186].
Small CAG-repeat RNAs in huntingtin gene pro-
duced neurotoxicity, thus indicating a pathogenic role
of abnormal RNA, in addition to the well-known dele-
terious effects of the abnormal protein product in HD
[187].
Hemoglobin was identified in neurons; reduced
expression of neuronal hemoglobin was shown in
AD, LBDs, and other neurodegenerative diseases
[188, 189]. The characteristics of the hemoglobin
and its possible function are being assessed, but
preliminary work suggests different molecular char-
acteristics than those of mature red blood cells,
relative independence of alpha and beta chains, and
possible functions not necessarily linked to oxygen
transport but rather to redox homeostasis.
We also reported a new familial behavioral
variant frontotemporal dementia associated with
astrocyte-predominant tauopathy not linked to MAPT
mutations but to a new FUS variation [190]; and
phenotypic variability within the inclusion body
spectrum of basophilic inclusion body disease and
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neuronal intermediate filament inclusion disease in
FTLD with FUS-positive inclusions [191]. Moving
to muscular diseases, a new cardiac and skeletal pro-
tein aggregate myopathy associated with combined
MuRF1 and MuRF3 mutation was identified [192].
The presence of olfactory and taste receptors, and
their obliged signaling pathways in the central ner-
vous system was discovered by serendipity during
the course of two separate gene expression arrays in
the human and mouse brain. The function of these
receptors is not known but it is likely not related to the
detection of odors and flavors. Probably, their func-
tion is rather associated to yet undeciphered archaic
autocrine or paracrine signaling system in nervous
system with specialized roles as it happens with other
ectopic olfactory and test receptors in other organs.
Olfactory receptors in dopaminergic cells react to
various external ligands thus indicating that they are
active receptors. Importantly, the expression of these
receptors is modulated in neurodegenerative diseases
with abnormal protein aggregates as in AD, PD, DLB,
and CJD in disease-dependent manner. Curiously,
some of them are downregulated but others (mainly
taste receptors) are usually upregulated [193–196].
The fact that the major risk factor of most neu-
rodegenerative diseases is aging, and that oxidative
stress and low levels of inflammation are character-
istic in the elderly, prompted us to study the putative
role of oxidative stress and inflammation in the
regional vulnerability linked to aging and major neu-
rodegenerative diseases, particularly AD. Our results
demonstrated that at around sixty-five years of age
there is a shift in the balance of oxidative stress and
oxidative stress responses with increased oxidative
damage; this is accompanied by altered expression of
certain lipids and fatty acids linked to inflammation.
However, at the local scale no clear relationship was
found among these factors, indicating that although
oxidative damage and inflammation occur in the aged
human brain, they are not sufficient to explain brain
regional vulnerability [197–200].
We also used murine models of -amyloidopathy,
tauopathy, AD, and HD, as well as mice expressing
human prion protein inoculated with CJD brain
homogenates to test putative agents directed to
altered metabolic pathways identified in human
studies [201–205]. Parallel experience with X-
ALD mice was useful to test several therapeutic
agents directed to specific targets in that model
[206–209]. In the same line, agents such as
triheptanoin supplementation to ketogenic diets,
rapamycin, poly-(propylene imine) glycodendrimers,
trans-resveratrol, carabamylated-erythropoietin,
fibrinogen-derived 377-395 peptide and levetirac-
etam derivatives were assessed in AD murine models.
Effects of lipid unsaturation diet on survival and
oxidative damage on murine models of ALS were
also assessed. Some treatments failed but others were
successful and were further analyzed in detail for pos-
sible application in human trials. The best candidates
in murine AD models were combinations of cannabi-
noids which can act through CB1 and CB2 receptors
[210–217]. The next step in this journey is the use of
a combination of cannabinoids in a clinical trial with
patients suffering from cognitive impairment and
early AD.
Historical notes
From 2010 to 2016, many important changes
occurred in the world. The Arab Spring or Arab Rev-
olution started as local revolts in 2010 and involved
in the subsequent months several countries such as
Tunisia, Egypt, Yemen, Syria, and Iraq. Uprisings
also occurred in other places: Algeria, Morocco,
Lebanon, Iran, Kuwait, Jordan, Bahrain, and Sudan.
Movements were directed against local oppressive
governments to install democracy. Yet substantial
revolts turned into civil wars; Tunisia seems to be the
only country in which an optimistic future is feasible
in the short term; Egypt is dominated by instability;
and Syria, Yemen, and Iraq are currently experienc-
ing bloody civil wars complicated by the dominance
of terrorist attacks from self-proclaimed ISIS and
many other minor groups. A new phenomenon of the
revolts was the use of social media—Twitter, Face-
book and other mobile applications—especially in
Tunisia and Egypt to get information of what was
happening in other places. No less important has
been the Al-Jazeera broadcast which has not satis-
fied the aspirations of governments of neighboring
countries.
Today, global terrorism is not limited to this region
but it also strikes Afghanistan, Pakistan, Central Asia,
the Philippines, Malaysia, Indonesia, and other coun-
tries throughout Asia. Russia and European countries
are continuous targets of suicide attacks. Boko-
Haram and other groups in the Sahel, particularly in
North Nigeria, are further sources of terror with local
impact.
In Spain, ETA was still active in the name of
democracy and freedom for the Basque country. We
must never forget that ETA was menacing, kidnap-
ping, and killing people during forty years after the
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end of the Franco regime in a fully democratic country
with full accomplishment of democracy.
The financial crisis in 2008 led to the loss of job
positions, and low salaries and alienation of lower
and middle classes. This occurred with increased
immigration from North Africa, Asia, the Middle
East, and Eastern European countries. There was
a rise in terrorism, and local interests have trig-
gered populist movements and incited a revival of old
nationalisms, instead of facilitating common policies
of all members of the European Union. In the past
few years, refugees escaping from the war in Syria
and other places of Middle East, and immigrants,
dying by the hundreds in the Mediterranean waters,
looking for better places to live instead of their origi-
nal Sub-Sahara countries, have invaded Europe. The
European Union has failed to solve this tremendous
humanitarian challenge with a common policy.
In Spain, this phenomenon has yielded the end
of bi-partisanship in Spanish government, and an
increase in nationalist ideology and separatism in
Catalonia.
Nationalist ideology boiled slowly for the last
twenty-five years and exploded following the refusal
of the central Government to carry out a local ille-
gal referendum to decide upon the willingness of the
Catalan people to be independent of Spain. However,
the scenario is severely contaminated: the former
Nationalist Party which governed Catalonia for more
than twenty-five years is being prosecuted for corrup-
tion and fraud for facilitating public and private work
to certain providers after receiving a percentage of the
total budget. Jordi Pujol, the father of modern Catalan
nationalism, and his family are accused of fraudulent
enrichment and capital flight to tax havens. The prob-
lem is very serious as it is not a simple opposition
between Catalonia and the Spanish Government, but
Catalonia itself is divided into two equal barely recon-
cilable parts, one dominated by the local government
generating state structures for a new nation/state with
unknown definition. Attempts to control the rule of
law, the lack of independence of the media, and indoc-
trination in the schools are certainly not guarantees of
democracy in the new regime. The other half of the
Catalan population is still amazed and incredulous
about the possibility of an independent Catalonia.
Additionally, arrogance and obstinacy of the Span-
ish Conservative party, and major divisions and lack
of negotiation among major political parties makes a
coordinated effort to find a negotiated solution all the
more difficult. Deep emotional feelings are not easily
buffered by reason.
Corruption is not exclusive to Catalonia but many
other local and state administrations are awaiting the
decisions of the courts. Corruption is, at present, one
of the recent discoveries of the hidden life of many
Spanish politicians, and the top echelon of banks and




The world’s population in 2017 is approximately
7,515,600,000 inhabitants: in Asia: 4,478,320,000;
in Africa: 1,246,510,000; in Europe: 739,210,000;
in Latin America: 647,570,000; in North Amer-
ica: 363,224,000; and in Oceania: 40,470,000.
Certain highlights matter: China: 1,372,100,000;
India: 1,282,000,000; USA: 328,130,000; Indone-
sia: 260,580,000; Nigeria: 191,840,000; Russia:
143,376,000; Japan: 126,050,000.
The global situation is complicated and there are
signals of change. A populist is leading the USA; his
aggressive behavior with his allies and the type of
introspective economic policy has no precedents in
this country. Russia is trying to establish and safe-
guard its borders in the South and West which were
lost in part after the fall of the USSR. At the same
time, Russia is a major provider of gas to Finland,
Germany, Ukraine, and other European countries.
China settled its borders invading Tibet and then con-
trolling the sources of the main Chinese waterways
and preserving these territories from the neighbors
in the South by the Himalayas, and also controlling
(albeit with continuous troubles) the remote region of
Xingjiang. Now China expands peacefully in Africa
creating macrostructures, railways, pipelines, and
connections at low cost, negotiating primary natural
products, and selling mobile phones and motorcy-
cles to a wide public. China also would like to have
its own control between the Pacific and the Atlantic
oceans beyond Panama by financing and controlling
a new canal in Nicaragua. Islamic countries in Africa
and Asia still need to overcome their internal ethnic
and religious barriers before being considered motors
of humanistic and scientific progress. Sub-Saharan
Africa is still a failed great promise. Central and South
America may progress in the coming years provided
that resources are better distributed and obsolete gov-
erns are replaced by democratic ones. Disarmament
and negotiations with the FARC and reduction of
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narcotrafficking in Colombia is encouraging, but the
situation is worsening in Mexico.
Europe seems to be breaking into pieces. The
UK has approved its intention to leave the Euro-
pean Union and several nationalist parties in different
countries defend a program of European involution.
Then this is time either for European dissolution or for
a European renaissance. Germany and France are the
main forces, but the other countries perhaps at differ-
ent velocities, are crucial as well. The spirit of people
like the recently deceased Simone Veil (President of
the European Parliament from 1979 to 1982) must be
present but also the idea that the concept of historic
nations has to be shifted to states, and to consider
Europe as a real emotional supranational structure
which would permit us to live together each preserv-
ing his or her original roots. However, in Spain we
must first nip in the bud the catfighting (best repre-
sented by Goya) between conceited political leaders,
and find a pact of the principal parties to reach a desir-
able understanding (Fig. 3). The potential roles of
Spain and Portugal as bridges between Europe and
Latin America are rather wishful thinking; Simon
Bolivar’s revolution and the subsequent subdivisions
in the North and West, and José de San Martı́ in
Argentina, eroded this eventuality in the early nine-
teenth century.
When I look at history and at my life, the myth of
Sisyphus comes to my mind. Sisyphus is represented
rolling an immense stone up a hill, only to watch
it come back repeating this action for eternity. It is
the vain contest of human beings to reach wisdom,
and the absurdity of looking for non-realistic goals.
However, the struggle itself is enough to fill a man’s
heart. It is as natural as the cycle of the sun rising and
shining every day, like the up and down movement of
the waves. Sisyphus is also onomatopoetic susurrant
sound (“siss phuss”) made by the breath in the nasal
passages.
Never-never land in my mind was created for plea-
sure against boredom and dystopia.
Personal notes
Regarding my position in the Hospital, I was
declared retired at the age of 65 years following the
Spanish law, with a remaining position of Senior
Consultant due to my duties as a Professor at the
University. As a result, I have no organizational,
management, or decision-making power. The Insti-
tute of Neuropathology does not exist anymore, and
the laboratories in the Bellvitge University Hospital,
including the laboratory for the study of prion dis-
eases, were dismantled in 2016 and 2017. The website
was sealed. More than 800 publications and 35 Doc-
toral Theses have been produced so far. Yet the
laboratories at the University and at the Hospital
Duran i Reynals are still active. New projects are on
the burners, and several pre-doctoral students have
to finish their work to obtain their PhDs. I will be
definitely retired at the age of 70.
Neuropathology has changed through this long
period. As in other countries, neuropathologists lost
strength in the hospitals because of the general
decrease in the number of general autopsies. The
creation of brain banks has balanced this situation
in many autonomous regions beyond the pioneer-
ing centers in Barcelona and Madrid. Generations of
young and middle-aged neuropathologists are hope-
ful indicators of the continuity of neuropathology
and availability of well-preserved brain samples for
research in Spain.
I have to admit that I was dyslexic and dysgraphic
before these conditions were recognized, and I man-
aged with these defects until now. Curiously, I have
X-linked color blindness, and I name and perceive
colors in a different way from what normal peo-
ple do. Yet I enjoy the fauves, impressionists, and
Fig. 3. Riña de gatos (cat fight), Francisco de Goya y Lucientes (1786); Museo del Prado, Madrid.
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Fig. 4. The Wait (Margot), Pablo Picasso (around 1901); Picasso Museum Barcelona. Other names: Morphine addict; Pierreuse, la main sur
l’epaule; Woman Made Up; Red Woman; Figure of Woman.
expressionists which are by far the artists I love the
best, in addition to Francisco de Goya, who rep-
resented the various and contrasting characteristics
of Spaniards in brilliant oils on canvas, engravings,
tapestries, cartoons, and drawings. I can spend days
marveling in front of such wise masterpieces (Fig. 4).
Alberto Giacometti’s sculptures are stirring and very
moving to me. I forgot to mention that I was practicing
sculpture before and at the time of studying medicine.
A bad experience in Paris frustrated dedication to this
ambition.
Regarding art, I am impressed before Romanesque
churches and Gothic cathedrals, and I am immersed in
a pleasant state inside the temples illuminated by the
light reflected across stained-glass windows. These
are manifestations of art, but they are also the result
of the successful application and balance of physical
forces carefully assessed by architects and crafts-
men working with stone, timber, metals, and glass.
Painting, sculpture, and music can also trigger deep
emotions related to happiness.
But the feeling of beauty may also occur in
science. I can envisage the feeling of beauty listen-
ing to apparently complex concepts such as curved
space, the quantum theory of energy, the forma-
tion of the universe, elementary particles, and dark
holes as revealed by physics, and more precisely by
physicists, throughout the last century. I feel plea-
sure and contentment after reading “On the Origin
of Species”, the “Structure of the nervous systems of
human and vertebrates”, and the theory of the double-
helix of DNA, provided that we have the basic insight
needed to capture the meanings of such tremendous
products of science. I can also enjoy the results of
our own experiments and the discoveries of other
scientists. I can discover beauty after elucidating
apparently minor aspects of molecular interactions
and biological processes.
Time has passed and I am not longer in the habit of
riding horses in the countryside of the mountain chain
that borders Barcelona to the northwest, nor do I go
snorkeling and diving in the Cap de Creus, where the
Pyrenees penetrate into the Mediterranean, as often
as I did years ago. But forests and the sea are still
exciting and impressive as they will forever be.
I believe that we also have a social commitment
and we need to be aware and generous to return
what we owe to the community. Scientists may not
be isolated in a world reduced to their experiments;
they have, like any other members of the human
collective, some obligations towards society. Hon-
esty, working against corruption and fraud, defense of
human rights, active involvement to protect children
and women worldwide, and respect for minorities, are
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Fig. 5. Hieronymous Bosch, The Extraction of the Stone of Madness (1501–1505), Museo Nacional El Prado, Madrid.
part of this goal. Esteem and caring for non-human
beings and nature are also important.
As in other activities, we need to have an open
mind about our culture and others, and about history.
We also need to be aware that our actions will have
repercussions on the people who come after us.
The path has not been and it is not easy; mis-
takes and errors have been common and still arise
although less frequently; disappointment and dis-
comfort occurred when the results were far below
my expectations; exasperation, disorientation, and
frustration appeared at times. However, we have
a lifespan to develop resilience, endurance, and
courage to improve our efforts to these ends.
Research, as well as other activities, depends on
the knowledge provided by other investigators and
colleagues. I am grateful to my teachers and men-
tors. I must manifest that my research has been, and
is, a combination of personal effort and the effort of
my collaborators, students, and technical and admin-
istrative staff. I am also pleased at having met a
considerable number of people worldwide, having
learned but also having enjoyed their conversations
and company. It is impossible here to name even
a mere few, but they probably already know my
affection for them.
NOTES ADDED IN PROOF
After writing the manuscript, two important events
occurred in Spain: 1) A radical Islamist terrorist
attack struck key touristic places in Barcelona the
17th and 18th of August 2017, killing sixteen and
wounding more than 100 people from many differ-
ent countries; and 2) The Parliament of Catalonia
approved the Referendum Law and the Transition
Policy Law, also known as the Law of Disconnec-
tion between Catalonia and Spain, the 6th and the
7th of September, respectively. The laws were
declared illegal by the Spanish Constitutional Court
and the Catalan High Court of Justice. Yet the
Catalan government did not care. The illegal refer-
endum was held the first of October; the Spanish
government clumsily responded with police repres-
sion while the regional police remained on the side
of the Catalan government. Unilateral independence
was declared by the President of the Autonomous
Government of Catalonia the night of the 10th of
October 2017, only to be annulled by the same
President 80 seconds later in an attempt to start nego-
tiations with the Spanish Government—mimicking
the scenario presented by Slovenia 27 years earlier in
the context of the break-up of Yugoslavia. The crisis
did not end that day but Catalan society itself defi-
nitely fell apart. The reconstruction of an acceptable
relationship between Catalonia and the rest of com-
munities in Spain will require the efforts of several
generations. If it were not so sad, the situation would
suggest the painting of Hieronymous Bosch (Fig. 5)
“The Extraction of the Stone of Madness”, or in some
aspects Pieter Bruegel “Landscape with the fall of
Icarus”.
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numbers of dendritic spines on cortical pyramidal neurons
in human chronic alcoholism. Neurosci Lett 69, 115-119.
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Phosphorylated MAP kinase (ERK1, ERK2) expression is
associated with early tau deposition in neurones and glial
cells, but not with increased nuclear DNA vulnerability
and cell death, in Alzheimer disease, Pick’s disease, pro-
gressive supranuclear palsy and corticobasal degeneration.
Brain Pathol 11, 144-158.
[62] Ferrer I, Blanco R, Carmona M (2001) Differential
expression of active, phosphorylation-dependent MAP
kinases, MAPK/ERK, SAPK/JNK and p38, and specific
transcription factor substrates following quinolinic acid
excitotoxicity in the rat. Mol Brain Res 94, 48-58.
[63] Ferrer I, Blanco R, Carmona M, Puig B, Bar-
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Escribano B, Olivé M (2005) Involvement of clusterin and
the aggresome in abnormal protein deposits in myofibril-
lar myopathies and inclusion body myositis. Brain Pathol
15, 101-108.
[100] Olive M, Goldfarb LG, Shatunov A, Fischer D, Fer-
rer I (2005) Myotilinopathy: Refining the clinical and
myopathological phenotype. Brain 128, 2315-2326.
[101] Janue A, Odena MA, Oliveira E, Olive M, Ferrer I (2007)
Desmin is oxidized and nitrated in affected muscles in
myotilinopathies and desminopathies. J Neuropathol Exp
Neurol 66, 711-723.
[102] Barrachina M, Moreno J, Juves S, Moreno D, Olive M,
Ferrer I (2007) Target genes of neuron-restrictive silencer
factor are abnormally up-regulated in human myotilinopa-
thy. Am J Pathol 171, 1312-1323.
[103] Ferrer I, Olive M (2008) Molecular pathology of myofib-
rillar myopathies. Expert Rev Mol Med 10, e25.
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AB, López de Munain A (2010) A novel PRNP Y218N
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rer I, Knecht E, Pujol A (2013) Oxidative stress regulates
the ubiquitin-proteasome system and immunoproteasome
functioning in a mouse model of X-adrenoleukodystrophy.
Brain 136, 891-904.
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